Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial

https://doi.org/10.1016/0022-510X(90)90015-FGet rights and content

Summary

Forty-four patients with mitochondrial myopathies were treated with Ubidecarenone (CoQ10) for 6 months in an open multi-center trial. No side effects of the drug were observed. Sixteen patients showing at least 25% decrease of post-exercise lactate levels were selected as responders. Responsiveness was apparently not related to CoQ10 level in serum and platelets or to the presence or absence of mtDNA deletions. The responders were treated for a further 3 months with CoQ10 or placebo in the second blind part of the trial; no significant differences were observed between the 2 groups. It is not clear why CoQ10 had therapeutic effects in some patients and not in others with the same clinical presentation and biochemical defect, and we failed to identify candidate responders before treatment. At the dose of CoQ10 used in this study (2 mg/kg/day) the therapy requires a long administration time before a response is seen.

References (42)

  • BerenbergR.A. et al.

    Lumping or splitting?

    Ophthalmoplegia plus or Kearns-Sayre syndrome

    Ann. Neurol.

    (1977)
  • BookelmannH. et al.

    Measurement of cytochromes in human skeletal muscle mitochondria isolated from fresh and frozen stored muscle specimens

    Biochem. Med.

    (1978)
  • BresolinN. et al.

    Clinical and biochemical correlations in mitochondrial myopathies treated with Coenzyme Q10

    Neurology

    (1988)
  • BresolinN. et al.

    Progressive cytochromec oxidase deficiency in a case of Kearns-Sayre syndrome: morphological and biochemical studies in muscle biopsies and autopsy tissues

    Ann. Neurol.

    (1987)
  • BresolinN. et al.

    Fatal infantile cytochromec oxidase deficiency: decrease of immunologically detectable enzyme in muscle

    Neurology

    (1985)
  • DesnuelleC. et al.

    Chronic progressive external ophtalmoplegia (CPEO) associated with diaphragm paralysis: successful treatment with Coenzyme Q (CoQ)

    Neurology

    (1989)
  • Di MauroS. et al.

    Progressive ophthalmoplegia, glycogen storage and abnormal mitochondria

    Arch. Neurol. 1973

    (1973)
  • Di MauroS. et al.

    Mitochondrial myopathy

    Ann. Neurol.

    (1985)
  • DrachmanD.A.

    Ophthalmoplegia plus: classification of disorders associated with progressive external ophthalmoplegia

  • FarleyT.M. et al.

    Response of genetically dystrophic mice to therapy with hexahydrocoenzyme Q4

    Biochem

    Biophys. Res. Commun.

    (1966)
  • Ferguson-MillerS. et al.

    Aggregation and diffusion in the mitochondrial electron-transfer chain: role in electron flow and energy transfer

    Biochem. Soc. Trans.

    (1986)
  • Cited by (0)

    View full text